Shenzhen Edge Medical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-175.03	-218.51	-212.87
Depreciation & Amortization	26.35	26	16.94
Other Amortization	1.8	2.28	1.93
Loss (Gain) From Sale of Assets	0.02	0.01	0.02
Asset Writedown & Restructuring Costs	1.43	1.43	-
Loss (Gain) From Sale of Investments	-15.73	-21.21	-36.97
Stock-Based Compensation	39.06	40.03	-13.66
Provision & Write-off of Bad Debts	4.25	1.03	0.55
Other Operating Activities	-13.05	-11.85	-11.77
Change in Accounts Receivable	-12.11	-11.53	-0.7
Change in Inventory	9.8	1.91	-74.14
Change in Accounts Payable	25.59	3.42	8.64
Change in Unearned Revenue	-5.9	-16.24	25.54
Change in Other Net Operating Assets	-74.61	-21.41	-23.81
Operating Cash Flow	-188.06	-224.64	-320.31
Capital Expenditures	-3.94	-26.39	-61.33
Sale of Property, Plant & Equipment	0.06	0.06	0.02
Sale (Purchase) of Intangibles	-0.38	-0.6	-2.27
Investment in Securities	183.32	221.46	445.41
Other Investing Activities	1.72	1.71	1.91
Investing Cash Flow	180.78	196.25	383.73
Long-Term Debt Repaid	-	-6.97	-7.39
Net Debt Issued (Repaid)	-6.92	-6.97	-7.39
Other Financing Activities	-1.17	-0.38	-1.8
Financing Cash Flow	-8.09	-7.34	-9.18
Foreign Exchange Rate Adjustments	-0.03	0.23	0.25
Net Cash Flow	-15.4	-35.5	54.5
Free Cash Flow	-192.01	-251.03	-381.64
Free Cash Flow Margin	-68.79%	-156.90%	-794.39%
Free Cash Flow Per Share	-0.53	-0.70	-1.06
Cash Interest Paid	0.7	0.86	0.99
Levered Free Cash Flow	-	-159.7	-
Unlevered Free Cash Flow	-	-159.16	-
Change in Working Capital	-57.23	-43.85	-64.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.